NA
RPRX icon

Networth Advisors’s Royalty Pharma RPRX Stock Holding History

Networth Advisors’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.87K Buy
+69
New +$3.59K ﹤0.01% 252
2026
Q1 		– Sell
-68
Closed -$2.63K – 437
2025
Q4 		$2.63K Buy
+68
New +$2.59K ﹤0.01% 241

Other funds holding RPRX

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Mitsubishi UFJ Trust & Banking
Mitsubishi UFJ Trust & Banking Tokyo, Japan $45.7B AUM 34.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
Daiwa Securities Group
Daiwa Securities Group Tokyo, Japan $51.1B AUM 35.55% 1-Year Est. Return

Networth Advisors's RPRX Position: Q2 2026 in Review

Networth Advisors opened a new position in Royalty Pharma (RPRX) in Q2 2026: 69 shares worth $3.87K. The stake represents ﹤0.01% of the portfolio and ranks #252 among its holdings. This is a return to the name: Networth Advisors previously reported a position in RPRX as recently as Q4 2025.

Networth Advisors first reported a position in RPRX in Q4 2025 and has held it in 2 quarters since. 257 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Networth Advisors held 69 shares of Royalty Pharma worth $3.87K as of Q2 2026.
  • Royalty Pharma was a new Networth Advisors position in Q2 2026.
  • Royalty Pharma made up ﹤0.01% of Networth Advisors's portfolio in Q2 2026, its #252 holding.
  • Networth Advisors first reported a position in Royalty Pharma in Q4 2025 and has held it in 2 quarters since.
  • 257 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Networth Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.